Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2019

01-10-2019 | Mastectomy | Breast Oncology

Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most?

Authors: Mark A. Taylor, MD, Chelsea McCarty Allen, PhD, Angela P. Presson, PhD, Morgan M. Millar, PhD, Rudi Zurbuchen, BS, Cindy B. Matsen, MD, MSCI, FACS

Published in: Annals of Surgical Oncology | Issue 10/2019

Login to get access

Abstract

Background

American Society of Breast Surgeons (ASBrS) guidelines state that it is the responsibility of the surgeon to discuss the risks/benefits of and give a recommendation regarding contralateral prophylactic mastectomy (CPM). We conducted a survey of ASBrS members to evaluate the factors that affect this recommendation, confidence in this recommendation, and awareness/adoption of the guidelines.

Methods

A survey was sent to the ASBrS membership. Vignettes with the following variables about breast cancer patient were randomly included: age, disease stage, receptor status, family history (FH) of breast cancer, and patient preference for CPM. Respondents were asked to estimate the patient’s chance of developing contralateral cancer, whether they would recommend CPM, and their confidence in this recommendation, and about their familiarity with and use of the guidelines.

Results

536 members (21.9%) responded. The odds of recommending CPM and confidence in recommendation were higher in a younger patient, higher-stage disease, triple-negative and human epidermal growth factor receptor (HER)2+ relative to estrogen receptor (ER)+, and in women with FH. Of surgeons, 51% were familiar or very familiar with the guidelines and 38% used the guidelines most or all of the time. Surgeons who used the guidelines were not less likely to recommend CPM.

Conclusions

While surgeons generally agree on the factors that are important in making a recommendation on CPM, there is variability in how strongly the different factors influence the recommendation and their confidence in that recommendation. In addition, while most surgeons were at least a little familiar with the ASBrS guidelines, the vast majority do not routinely use them.
Literature
1.
go back to reference Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9CrossRefPubMed Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9CrossRefPubMed
2.
go back to reference Soran A, Kamali Polat A, Johnson R, McGuire KP. Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon? Surgeon. 2014;12(6):316–22CrossRefPubMed Soran A, Kamali Polat A, Johnson R, McGuire KP. Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon? Surgeon. 2014;12(6):316–22CrossRefPubMed
3.
go back to reference Burke EE, Portschy PR, Tuttle TM. Prophylactic mastectomy: who needs it, when and why. J Surg Oncol. 2015;111(1):91–5CrossRefPubMed Burke EE, Portschy PR, Tuttle TM. Prophylactic mastectomy: who needs it, when and why. J Surg Oncol. 2015;111(1):91–5CrossRefPubMed
4.
go back to reference Dragun AE, Pan J, Riley EC, et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013;36(4):375–80CrossRefPubMed Dragun AE, Pan J, Riley EC, et al. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013;36(4):375–80CrossRefPubMed
5.
go back to reference Buchanan PJ, Abdulghani M, Waljee JF, et al. An analysis of the decisions made for contralateral prophylactic mastectomy and breast reconstruction. Plast Reconstr Surg. 2016;138(1):29–40CrossRefPubMed Buchanan PJ, Abdulghani M, Waljee JF, et al. An analysis of the decisions made for contralateral prophylactic mastectomy and breast reconstruction. Plast Reconstr Surg. 2016;138(1):29–40CrossRefPubMed
6.
go back to reference Angelos P, Bedrosian I, Euhus DM, Herrmann VM, Katz SJ, Pusic A. Contralateral prophylactic mastectomy: challenging considerations for the surgeon. Ann Surg Oncol. 2015;22(10):3208–12CrossRefPubMedPubMedCentral Angelos P, Bedrosian I, Euhus DM, Herrmann VM, Katz SJ, Pusic A. Contralateral prophylactic mastectomy: challenging considerations for the surgeon. Ann Surg Oncol. 2015;22(10):3208–12CrossRefPubMedPubMedCentral
7.
go back to reference Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17(10):2554–62CrossRefPubMed Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17(10):2554–62CrossRefPubMed
8.
9.
go back to reference Baker SK, Mayer DK, Esposito N. The contralateral prophylactic mastectomy decision-making process. Plast Surg Nurs. 2013;33(1):11–21; quiz 22–13CrossRefPubMed Baker SK, Mayer DK, Esposito N. The contralateral prophylactic mastectomy decision-making process. Plast Surg Nurs. 2013;33(1):11–21; quiz 22–13CrossRefPubMed
10.
go back to reference Hawley ST, Lantz PM, Janz NK, et al. Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient Educ Couns. 2007;65(3):387–95CrossRefPubMed Hawley ST, Lantz PM, Janz NK, et al. Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient Educ Couns. 2007;65(3):387–95CrossRefPubMed
11.
go back to reference de Haes H. Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Educ Couns. 2006;62(3):291–98CrossRefPubMed de Haes H. Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Educ Couns. 2006;62(3):291–98CrossRefPubMed
12.
go back to reference Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Social Sci Med (1982). 1997;44 Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Social Sci Med (1982). 1997;44
13.
14.
go back to reference Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27 Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27
15.
go back to reference Bellavance E, Peppercorn J, Kronsberg S, et al. Surgeons’ perspectives of contralateral prophylactic mastectomy. Ann Surg Oncol. 2016;23(9):2779–87CrossRefPubMed Bellavance E, Peppercorn J, Kronsberg S, et al. Surgeons’ perspectives of contralateral prophylactic mastectomy. Ann Surg Oncol. 2016;23(9):2779–87CrossRefPubMed
16.
go back to reference Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16(10):2697–704CrossRefPubMed Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16(10):2697–704CrossRefPubMed
17.
go back to reference Katz SJ, Janz NK, Abrahamse P, et al. Patient reactions to surgeon recommendations about contralateral prophylactic mastectomy for treatment of breast cancer. JAMA Surg. 2017;152(7):658–64CrossRefPubMedPubMedCentral Katz SJ, Janz NK, Abrahamse P, et al. Patient reactions to surgeon recommendations about contralateral prophylactic mastectomy for treatment of breast cancer. JAMA Surg. 2017;152(7):658–64CrossRefPubMedPubMedCentral
18.
go back to reference Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks. Ann Surg Oncol. 2016;23(10):3100–5CrossRefPubMedPubMedCentral Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks. Ann Surg Oncol. 2016;23(10):3100–5CrossRefPubMedPubMedCentral
19.
go back to reference Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy consensus statement from the American Society of Breast Surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23(10):3106–11CrossRefPubMedPubMedCentral Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy consensus statement from the American Society of Breast Surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23(10):3106–11CrossRefPubMedPubMedCentral
20.
go back to reference Chowdhury M, Euhus D, Onega T, Biswas S, Choudhary PK. A model for individualized risk prediction of contralateral breast cancer. Breast Cancer Res Treat. 2017;161(1):153–60CrossRefPubMed Chowdhury M, Euhus D, Onega T, Biswas S, Choudhary PK. A model for individualized risk prediction of contralateral breast cancer. Breast Cancer Res Treat. 2017;161(1):153–60CrossRefPubMed
21.
go back to reference Rusner C, Wolf K, Bandemer-Greulich U, et al. Risk of contralateral second primary breast cancer according to hormone receptor status in Germany. Breast Cancer Res. 2014;16(5):452CrossRefPubMedPubMedCentral Rusner C, Wolf K, Bandemer-Greulich U, et al. Risk of contralateral second primary breast cancer according to hormone receptor status in Germany. Breast Cancer Res. 2014;16(5):452CrossRefPubMedPubMedCentral
22.
go back to reference Saltzman BS, Malone KE, McDougall JA, Daling JR, Li CI. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer. Breast Cancer Res Treat. 2012;135(3):849–55CrossRefPubMedPubMedCentral Saltzman BS, Malone KE, McDougall JA, Daling JR, Li CI. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer. Breast Cancer Res Treat. 2012;135(3):849–55CrossRefPubMedPubMedCentral
23.
go back to reference Reiner AS, Lynch CF, Sisti JS, et al. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Res. 2017;19(1):83CrossRefPubMedPubMedCentral Reiner AS, Lynch CF, Sisti JS, et al. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Breast Cancer Res. 2017;19(1):83CrossRefPubMedPubMedCentral
24.
go back to reference Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Glazebrook KN, Hieken TJ. Contralateral prophylactic mastectomy for women with T4 locally advanced breast cancer. Ann Surg Oncol. 2016;23(10):3365–70CrossRefPubMed Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Glazebrook KN, Hieken TJ. Contralateral prophylactic mastectomy for women with T4 locally advanced breast cancer. Ann Surg Oncol. 2016;23(10):3365–70CrossRefPubMed
25.
go back to reference Panchal H, Pilewskie ML, Sheckter CC, et al. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer. J Surg Oncol. 2019;119(1):79–87CrossRefPubMed Panchal H, Pilewskie ML, Sheckter CC, et al. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer. J Surg Oncol. 2019;119(1):79–87CrossRefPubMed
26.
go back to reference Elwyn G, Cochran N, Pignone M. Shared decision making-the importance of diagnosing preferences. JAMA Intern Med. 2017;177(9):1239–40CrossRefPubMed Elwyn G, Cochran N, Pignone M. Shared decision making-the importance of diagnosing preferences. JAMA Intern Med. 2017;177(9):1239–40CrossRefPubMed
27.
go back to reference Nass SJ, Nekhlyudov L. Commentary on the consensus statement of the American Society of Breast Surgeons on contralateral prophylactic mastectomy. Ann Surg Oncol. 2017;24(3):611–3CrossRefPubMed Nass SJ, Nekhlyudov L. Commentary on the consensus statement of the American Society of Breast Surgeons on contralateral prophylactic mastectomy. Ann Surg Oncol. 2017;24(3):611–3CrossRefPubMed
28.
go back to reference Politi MC, Street RL, Jr. The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty. J Eval Clin Pract. 2011;17(4):579–84CrossRefPubMed Politi MC, Street RL, Jr. The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty. J Eval Clin Pract. 2011;17(4):579–84CrossRefPubMed
29.
go back to reference Politi MC, Legare F. Physicians’ reactions to uncertainty in the context of shared decision making. Patient Educ Couns. 2010;80(2):155–7CrossRefPubMed Politi MC, Legare F. Physicians’ reactions to uncertainty in the context of shared decision making. Patient Educ Couns. 2010;80(2):155–7CrossRefPubMed
Metadata
Title
Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most?
Authors
Mark A. Taylor, MD
Chelsea McCarty Allen, PhD
Angela P. Presson, PhD
Morgan M. Millar, PhD
Rudi Zurbuchen, BS
Cindy B. Matsen, MD, MSCI, FACS
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07561-y

Other articles of this Issue 10/2019

Annals of Surgical Oncology 10/2019 Go to the issue